Best Vascular/Novoste, a TeamBest Global Company, Completes 17 Years Under TeamBest Global Management

Best Vascular/Novoste, a TeamBest Global Company, Completes 17 Years Under TeamBest Global Management

Washington, DC, USA – (EIN PRESSWIRE) – March 29, 2023

Best Vascular/Novoste celebrated a major milestone this month — completing 17 years under the management of TeamBest Global (TBG).

Best Medical International (BMI), one of the TeamBest Global Companies, has been in Vascular Brachytherapy (VBT) for over 30 years.  Starting in 1992, BMI engaged in pre-clinical research in animals with Dr. Ron Waksman of Washington Hospital Center in Washington, D.C., (at Emory University until 1997) and Dr. Ian Crocker at Emory University in Atlanta, Georgia and also starting in 1994, carried out Phase I Human Clinical Trials with Dr. Paul Teirstein, Dr. Vince Mazzoula and Dr. Shiresh Jani of Scripps Clinic, La Jolla, California.

Novoste was established in 1995 and became a public company soon thereafter.  In January 1996, at the very first Vascular Brachytherapy Conference in Atlanta, Georgia, BMI tried to work with Novoste and again in early 2004, but had little success in working with the Novoste management in place at that time.

Novoste assets were purchased by BMI in March 2006 as Novoste was planning to close down the Vascular Therapy operation.

VBT was approved for clinical use by US FDA on November 3, 2000.  BMI continues to support and expand the use of VBT and is currently involved in developing new technologies.

Thanks to everyone for their wisdom, guidance, support, encouragement, help and blessings, dedication and hard/team work in saving many 1000s of lives.

For more details and information, please click here to view the original press release.

Click here to download the PDF.